Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $3.9 billion.

  • United Therapeutics' Non-Current Assets rose 2351.81% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 billion, marking a year-over-year increase of 1637.65%. This contributed to the annual value of $3.5 billion for FY2024, which is 348.17% down from last year.
  • Latest data reveals that United Therapeutics reported Non-Current Assets of $3.9 billion as of Q3 2025, which was up 2351.81% from $4.1 billion recorded in Q2 2025.
  • Over the past 5 years, United Therapeutics' Non-Current Assets peaked at $4.1 billion during Q2 2025, and registered a low of $2.5 billion during Q2 2021.
  • For the 5-year period, United Therapeutics' Non-Current Assets averaged around $3.2 billion, with its median value being $3.1 billion (2024).
  • In the last 5 years, United Therapeutics' Non-Current Assets skyrocketed by 3572.55% in 2023 and then crashed by 1239.94% in 2024.
  • Quarter analysis of 5 years shows United Therapeutics' Non-Current Assets stood at $2.8 billion in 2021, then fell by 6.37% to $2.7 billion in 2022, then soared by 35.73% to $3.6 billion in 2023, then decreased by 3.48% to $3.5 billion in 2024, then rose by 10.52% to $3.9 billion in 2025.
  • Its Non-Current Assets was $3.9 billion in Q3 2025, compared to $4.1 billion in Q2 2025 and $3.8 billion in Q1 2025.